| · Personal control
· Shipman
· Animal testing
· Charter
· Statins
· Cholesterol testing
· Media scrutiny
· Retention fee
· Enhanced services
Letters to the Editor
|
Charter
SOS council members should resign
From Mr J. T. Mearns, FRPharmS
The result of the referendum has shown that the “small but vocal
minority” has been unable to stir the “silent majority” into
action.
The changes in the Charter advocated by the SOS have caused the Society
a great deal of extra work. I suggest that all SOS members of Council
resign immediately as this would be a sure sign for the Privy Council
that there would be a “light at the end of the tunnel”.
James T. Mearns
Westbury on Trym,
Bristol
Membership owes the SOS four
From Mr J. Gentle, MRPharmS
It has now been widely recognised that the August 2004 version of the
Charter is a members’ Charter, whereas the December 2003 version
would never have been acceptable to the membership. Martin
Astbury in his
letter (PJ, 4 September, p311) sets out clearly as to how we arrived at
this much more favourable position.
He states that the Privy Council was prevented from approving the now discredited
December Charter solely because of the legal action brought by the Save
Our Society four. However, these four individuals have, by all accounts,
accrued enormous legal bills – I believe that these are in excess
of £300,000.
I feel that the membership owes the Save Our Society four a huge debt of
gratitude. Their courage in bringing this action gave the new Council the
opportunity to re-draft the Charter to a more acceptable version, and gave
the membership the opportunity to have a say in whether or not that version
should be submitted to the Privy Council.
While the Save Our Society group comprises many like-minded pharmacists,
among them candidates in the past two Council elections and past presidents
of the Society, the action was brought in the name of just four members.
Surely the action of these four should be recognised by all members, and
that every assistance should be given to them in meeting the costs of that
action.
John Gentle
Shrewsbury, Shropshire |
The
Pharmaceutical Journal